CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE
4.1 Overview
4.1.1 Market size and forecast
4.2 imaging
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 laboratory tests
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 endoscopy
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 biopsy
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: LIVER DISEASE DIAGNOSTICS MARKET, BY END USE
5.1 Overview
5.1.1 Market size and forecast
5.2 hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 laboratories
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: LIVER DISEASE DIAGNOSTICS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Technique
6.2.3 North America Market size and forecast, by End Use
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Technique
6.2.4.1.2 Market size and forecast, by End Use
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Technique
6.2.4.2.2 Market size and forecast, by End Use
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Technique
6.2.4.3.2 Market size and forecast, by End Use
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Technique
6.3.3 Europe Market size and forecast, by End Use
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Technique
6.3.4.1.2 Market size and forecast, by End Use
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Technique
6.3.4.2.2 Market size and forecast, by End Use
6.3.4.3 UK
6.3.4.3.1 Market size and forecast, by Technique
6.3.4.3.2 Market size and forecast, by End Use
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Technique
6.3.4.4.2 Market size and forecast, by End Use
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Technique
6.3.4.5.2 Market size and forecast, by End Use
6.3.4.6 Rest of Europe
6.3.4.6.1 Market size and forecast, by Technique
6.3.4.6.2 Market size and forecast, by End Use
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Technique
6.4.3 Asia-Pacific Market size and forecast, by End Use
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Technique
6.4.4.1.2 Market size and forecast, by End Use
6.4.4.2 Japan
6.4.4.2.1 Market size and forecast, by Technique
6.4.4.2.2 Market size and forecast, by End Use
6.4.4.3 India
6.4.4.3.1 Market size and forecast, by Technique
6.4.4.3.2 Market size and forecast, by End Use
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Technique
6.4.4.4.2 Market size and forecast, by End Use
6.4.4.5 Australia
6.4.4.5.1 Market size and forecast, by Technique
6.4.4.5.2 Market size and forecast, by End Use
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Technique
6.4.4.6.2 Market size and forecast, by End Use
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Technique
6.5.3 LAMEA Market size and forecast, by End Use
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Market size and forecast, by Technique
6.5.4.1.2 Market size and forecast, by End Use
6.5.4.2 Saudi Arabia
6.5.4.2.1 Market size and forecast, by Technique
6.5.4.2.2 Market size and forecast, by End Use
6.5.4.3 South Africa
6.5.4.3.1 Market size and forecast, by Technique
6.5.4.3.2 Market size and forecast, by End Use
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Market size and forecast, by Technique
6.5.4.4.2 Market size and forecast, by End Use
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Bio-Rad Laboratories Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Cosara Diagnostics Pvt Ltd
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Echosens
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Meril Life Sciences Pvt. Ltd.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 PerkinElmer
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Qiagen N.V.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Siemen’s AG
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Thermo Fisher Scientific Inc.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Trivitron Healthcare
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
TABLE 1. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 2. LIVER DISEASE DIAGNOSTICS MARKET, FOR IMAGING, BY REGION, 2021-2031 ($MILLION)
TABLE 3. LIVER DISEASE DIAGNOSTICS MARKET FOR IMAGING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. LIVER DISEASE DIAGNOSTICS MARKET, FOR LABORATORY TESTS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. LIVER DISEASE DIAGNOSTICS MARKET FOR LABORATORY TESTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. LIVER DISEASE DIAGNOSTICS MARKET, FOR ENDOSCOPY, BY REGION, 2021-2031 ($MILLION)
TABLE 7. LIVER DISEASE DIAGNOSTICS MARKET FOR ENDOSCOPY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. LIVER DISEASE DIAGNOSTICS MARKET, FOR BIOPSY, BY REGION, 2021-2031 ($MILLION)
TABLE 9. LIVER DISEASE DIAGNOSTICS MARKET FOR BIOPSY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 11. LIVER DISEASE DIAGNOSTICS MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. LIVER DISEASE DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. LIVER DISEASE DIAGNOSTICS MARKET, FOR LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 14. LIVER DISEASE DIAGNOSTICS MARKET FOR LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. LIVER DISEASE DIAGNOSTICS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. LIVER DISEASE DIAGNOSTICS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. LIVER DISEASE DIAGNOSTICS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. U.S. LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 22. U.S. LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 23. CANADA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 24. CANADA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 25. MEXICO LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 26. MEXICO LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 27. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 28. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 29. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. GERMANY LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 31. GERMANY LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 32. FRANCE LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 33. FRANCE LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 34. UK LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 35. UK LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 36. ITALY LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 37. ITALY LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 38. SPAIN LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 39. SPAIN LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 40. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 41. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 42. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 43. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 44. ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. CHINA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 46. CHINA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 47. JAPAN LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 48. JAPAN LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 49. INDIA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 50. INDIA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 51. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 52. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 53. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 54. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 55. REST OF ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 57. LAMEA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 58. LAMEA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 59. LAMEA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 60. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 61. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 62. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 63. SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 64. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 65. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 66. REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE, 2021-2031 ($MILLION)
TABLE 67. REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, BY END USE, 2021-2031 ($MILLION)
TABLE 68.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 69.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 70.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 71.ABBOTT LABORATORIES: NET SALES,
TABLE 72.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 73.BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
TABLE 74.BIO-RAD LABORATORIES INC.: OPERATING SEGMENTS
TABLE 75.BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 76.BIO-RAD LABORATORIES INC.: NET SALES,
TABLE 77.BIO-RAD LABORATORIES INC.: KEY STRATERGIES
TABLE 78.COSARA DIAGNOSTICS PVT LTD: COMPANY SNAPSHOT
TABLE 79.COSARA DIAGNOSTICS PVT LTD: OPERATING SEGMENTS
TABLE 80.COSARA DIAGNOSTICS PVT LTD: PRODUCT PORTFOLIO
TABLE 81.COSARA DIAGNOSTICS PVT LTD: NET SALES,
TABLE 82.COSARA DIAGNOSTICS PVT LTD: KEY STRATERGIES
TABLE 83.ECHOSENS: COMPANY SNAPSHOT
TABLE 84.ECHOSENS: OPERATING SEGMENTS
TABLE 85.ECHOSENS: PRODUCT PORTFOLIO
TABLE 86.ECHOSENS: NET SALES,
TABLE 87.ECHOSENS: KEY STRATERGIES
TABLE 88.MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 89.MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 90.MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 91.MERIL LIFE SCIENCES PVT. LTD.: NET SALES,
TABLE 92.MERIL LIFE SCIENCES PVT. LTD.: KEY STRATERGIES
TABLE 93.PERKINELMER: COMPANY SNAPSHOT
TABLE 94.PERKINELMER: OPERATING SEGMENTS
TABLE 95.PERKINELMER: PRODUCT PORTFOLIO
TABLE 96.PERKINELMER: NET SALES,
TABLE 97.PERKINELMER: KEY STRATERGIES
TABLE 98.QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 99.QIAGEN N.V.: OPERATING SEGMENTS
TABLE 100.QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 101.QIAGEN N.V.: NET SALES,
TABLE 102.QIAGEN N.V.: KEY STRATERGIES
TABLE 103.SIEMEN’S AG: COMPANY SNAPSHOT
TABLE 104.SIEMEN’S AG: OPERATING SEGMENTS
TABLE 105.SIEMEN’S AG: PRODUCT PORTFOLIO
TABLE 106.SIEMEN’S AG: NET SALES,
TABLE 107.SIEMEN’S AG: KEY STRATERGIES
TABLE 108.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 109.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 110.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 111.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 112.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 113.TRIVITRON HEALTHCARE: COMPANY SNAPSHOT
TABLE 114.TRIVITRON HEALTHCARE: OPERATING SEGMENTS
TABLE 115.TRIVITRON HEALTHCARE: PRODUCT PORTFOLIO
TABLE 116.TRIVITRON HEALTHCARE: NET SALES,
TABLE 117.TRIVITRON HEALTHCARE: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
